All In MedTech

Device Trial Radar · NCT05683938

GentleCath™ Air Intermittent Catheter Smartwatch Real Life Pilot Study

Last checked: Nov 20, 2026Latest source record: Apr 30, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

72

Actual

Start

Nov 18, 2021

Primary completion

Apr 26, 2023

Study completion Apr 26, 2023

Sponsor

Lead sponsor
ConvaTec Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jan 13, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
Female only, from 18 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

As part of the ongoing Clinical Evaluation and Post Market Clinical Follow Up (PMCF) activities it was determined that a pilot study should be conducted to look at how real life data such as various physiological measurements can be collected via a Smart-Watch during intermittent self-catheterisation whilst also collecting real life feedback from users on comfort as measured by levels of possible discomfort and on levels of anxiety which may be associated with intermittent catheterisation over a period of time. Adherence to catheter regimen and proper emptying of the bladder is of clinical relevance for clean intermittent catheterisation. A Daily Fluid Diary is included in this pilot study together with the use of the microphone of the Apple™ Smart Watch to investigate the feasibility of tracking input and output of fluids. The user acceptance of the Daily Fluid Diary offered via the iPhone app and the feasibility of the microphone to capture bladder emptying or voiding are to be tested within this pilot.

Conditions

  • Neurogenic Bladder

Interventions

  • Intermittent self-catheterisationDevice

    GentleCath™ Air intermittent catheter

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To collect physiological measurements associated with self-catheterisation using an Apple™ Watch 6.0, an iPhone SE 2020 and a Polar H10 chest-strap plus a software applicationTime frame: 28 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Kings College Hospital

    London, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.